Nanobiotix nomme un nouveau directeur médical à la suite de son autorisation de mise sur le marché européen

NEXT STORY
New Data on Curetis’ Unyvero LRT Panel for Pneumonia to be Presented at ASM Microbe 2019
PREV STORY
Sequana Medical Announces Unconditional IDE Approval from U.S. FDA to Start alfapump® Pivotal Study (POSEIDON)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

OSE Immunotherapeutics Presented New Translational Data on Tedopi® and Preclinical Data on PD-1/IL-7 Bifunctional Program BiCKI®-IL-7

author_avatar
NASDAQ Market News

Cellceutix Announces Appointment of Vice President for Regulatory Affairs

BEVERLY, MA--(Marketwired - September 16, 2016) - Cellceutix Corporation, (OTC: CTIX) ("the Company"), a ...

author_avatar
NASDAQ Market News

The Worldwide Infusion Pumps Industry is Expected to Reach $18.8 Billion in 2025 at a CAGR of 7.34% from 2021

author_avatar
NASDAQ Market News